Pascal and Francis Bibliographic Databases


Search results

Your search

kw.\*:("Antagoniste dopamine")


A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV


A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV


A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 5930

  • Page / 238


Selection :

  • and

Effects of thioridazine and its metabolites on dopaminergic function: drug metabolism as a determinant of the antidopaminergic actions of thioridazineKILTS, C. D; KNIGHT, D. L; MAILMAN, R. B et al.The Journal of pharmacology and experimental therapeutics. 1984, Vol 231, Num 2, pp 334-342, issn 0022-3565Article

Pharmacological effects of a specific dopamine D-1 antagonist SCH 23390 in comparison with neurolepticsCHRISTENSEN, A. V; ARNT, J; HYTTEL, J et al.Life sciences (1973). 1984, Vol 34, Num 16, pp 1529-1540, issn 0024-3205Article

Myoclonus induced by metoclorpamide therapyHYSER, C. L; DRAKE, M. E. JR.Archives of internal medicine (1960). 1983, Vol 143, Num 11, pp 2201-2202, issn 0003-9926Article

Clonidine reverses methylxanthine-induced potentiation of baclofen antinociceptionSTEARDO, L; SAWYNOK, J.Pharmacology, biochemistry and behavior. 1985, Vol 22, Num 5, pp 905-907, issn 0091-3057Article

The D1 dopamine receptor antagonist, SCH 23390 reduces locomotor activity and rearing in ratsHOFFMAN, D. C; BENINGER, R. J.Pharmacology, biochemistry and behavior. 1985, Vol 22, Num 2, pp 341-342, issn 0091-3057Article

Highlights of D1 dopamine receptor antagonist researchBARNETT, A; MCQUADE, R. D; TEDFORD, C et al.Neurochemistry international. 1992, Vol 20, Num MAR, pp 119S-122S, issn 0197-0186, SUPConference Paper

SCH 23390, a selective dopamine D1 antagonist, activates dopamine neurons but fails to prevent their inhibition by apomorphineMEREU, G; COLLU, M; ONGINI, E et al.European journal of pharmacology. 1985, Vol 111, Num 3, pp 393-396, issn 0014-2999Article

Effet natriurétique de l'halopéridol chez le chien = Natriuretic effect of haloperidol in dogsCUCHE, J. L; PRINSEAU, J; BAGLIN, A et al.Néphrologie (Genève). 1983, Vol 4, Num 3, pp 103-105, issn 0250-4960Article

Interaction of dopamine receptor ligands with subtypes of the opiate receptorBOUBLIK, J. H; FUNDER, J. W.European journal of pharmacology. 1985, Vol 107, Num 1, pp 11-16, issn 0014-2999Article

Essai de correction de l'hypotension orthostatique par le dompéridone = Treatment of orthostatic hypotension with domperidoneMONTASTRUC, J. L; CHAMONTIN, B; SENARD, J. M et al.Thérapie (Paris). 1984, Vol 39, Num 6, pp 709-711, issn 0040-5957Article

Effect of haloperidol on dopamine-induced increase in renal blood flowARMSTRONG, D. K; DASTA, J. F; REILLEY, T. E et al.Drug intelligence & clinical pharmacy. 1986, Vol 20, Num 7-8, pp 543-546, issn 0012-6578Article

Characterization of the binding of 3H-SCH 23390, a selective D-1 receptor antagonist ligand, in rat striatumBILLARD, W; RUPERTO, V; CROSBY, G et al.Life sciences (1973). 1984, Vol 35, Num 18, pp 1885-1893, issn 0024-3205Article

The chemical basis for the blockade of the D-1 dopamine receptor by SCH 23390ITOH, Y; BEAULIEU, M; KEBARIAN, J. W et al.European journal of pharmacology. 1984, Vol 100, Num 1, pp 119-122, issn 0014-2999Article

Increased forearm vascular resistance after dopamine blockadeMANNERING, D; BENNETT, E. D; MEHTA, N et al.British journal of clinical pharmacology. 1984, Vol 17, Num 4, pp 373-378, issn 0306-5251Article

Etude de l'action du véralipride sur les bouffées vasomotrices de la ménopause et exploration de la tolérance endocrinienne de ce composé = Study of the action of veralipride on the vasomotor flushes during menopause and examination of endocrine tolerance of this compoundCRUCIANI, M; ROULIER, R.Revue française de gynécologie et d'obstétrique. 1983, Vol 78, Num 7-9, pp 581-583, issn 0035-290XArticle

Treatment of Tourette disorder with penfluridolSHAPIRO, A. K; SHAPIRO, E; EISENKRAFT, G. J et al.Comprehensive psychiatry. 1983, Vol 24, Num 4, pp 327-331, issn 0010-440XArticle

Effects of metoclopramide, a dopamine antagonist, on secretion of aldosterone and renin release in patients with primary aldosteronismMIZUNO, K; YAMAZAKI, M.-A; IKEDA, K et al.Japanese heart journal. 1984, Vol 24, Num 6, pp 917-924, issn 0021-4868Article

Neuroleptic-like anorexia produced by an extra-cerebral DA antagonistWILLIS, G. L; SMITH, G. C; KINCHINGTON, P. C et al.Brain research bulletin. 1983, Vol 11, Num 1, pp 21-24, issn 0361-9230Article

Functional evidence for selective dopamine D-1 receptor blockade by SCH 23390HYTTEL, J.Neuropharmacology. 1984, Vol 23, Num 12A, pp 1395-1401, issn 0028-3908Article

The effect of spiroperidol on tonic immobility in domestic fowlHENNIG, C. W; SPENCER, B. D.Bulletin of the Psychonomic Society. 1983, Vol 21, Num 4, pp 317-320, issn 0090-5054Article


Increased ventilatory chemosensitivity induced by domperidone, a dopamine antagonist, in healthy humansDELPIERRE, S; FORNARIS, M; GUILLOT, C et al.Clinical respiratory physiology. 1987, Vol 23, Num 1, pp 31-35, issn 0272-7587Article

Dopamine blockage inhibits starvation ketosis in manJOHNSTON, D. G; BLESA-MALPICA, G; BURRIN, J. M et al.Clinical endocrinology (Oxford. Print). 1983, Vol 19, Num 3, pp 389-396, issn 0300-0664Article

Dopamine receptor subtypes: in vivo biochemical evidence for functional interactionSALLER, C. F; SALAMA, A. I.European journal of pharmacology. 1985, Vol 109, Num 2, pp 297-300, issn 0014-2999Article

Agréal: expérience clinique. Revue de la littérature = Agreal: clinical experience. Review of the literatureBRIENT-CLABAUX, J.Revue française de gynécologie et d'obstétrique. 1985, Vol 80, Num 3, pp 143-146, issn 0035-290XArticle

  • Page / 238